Literature DB >> 24210785

Validation of an automated blood culture system for sterility testing of cell therapy products.

Didier Hocquet1, Marlène Sauget2, Sandrine Roussel3, Caroline Malugani4, Fabienne Pouthier5, Pascal Morel5, Houssein Gbaguidi-Haore2, Xavier Bertrand2, Frédéric Grenouillet3.   

Abstract

BACKGROUND AIMS: Automated blood culture systems are widely used for the detection of microorganisms in cell therapy products. However, they are not validated by the manufacturers for this purpose. The aim of this study was to assess the ability of the Bactec system (Becton-Dickinson, Le Pont-De-Claix, France) to detect the microorganisms that could contaminate cell therapy products.
METHODS: Three types of vials and conditions were tested: Plus Aerobic/F and Anaerobic/F media incubated at 35°C and Mycosis IC/F medium incubated at 30°C. All vials were incubated 10 days. We tested 18 microorganisms, including slow growers and some with fastidious nutritional requirements (10 bacteria, four yeasts, four filamentous fungi), each with four inocula (10-10(4) colony-forming units) performed in quintuplicate.
RESULTS: The combination of Plus Aerobic/F and Plus Anaerobic/F vials detected all the tested pathogenic bacteria, all the tested Gram-positive skin commensal or environmental bacteria, all the tested yeasts, and three of four tested filamentous fungi. The addition of the Mycosis IC/F vial extended the range of detected microorganisms to one fungal environmental contaminant. Two bacterial environmental contaminants were not detected by our method. Low inocula of the skin contaminant Propionibacterium acnes were detected only after 7 days of incubation.
CONCLUSIONS: These data suggest that (i) the prolongation of the incubation time of Plus Aerobic/F and Plus Anaerobic/F vials from 7 to 10 days and (ii) the use of Mycosis IC/F medium make minor contributions in the sterility testing of cell therapy products. We have validated the Bactec method using aerobic and anaerobic vials incubated 7 days at 35°C.
Copyright © 2014 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  automated blood culture systems; cell therapy product; microbial contamination; sterility testing

Mesh:

Substances:

Year:  2013        PMID: 24210785     DOI: 10.1016/j.jcyt.2013.09.005

Source DB:  PubMed          Journal:  Cytotherapy        ISSN: 1465-3249            Impact factor:   5.414


  6 in total

Review 1.  Manufacture of tumor- and virus-specific T lymphocytes for adoptive cell therapies.

Authors:  X Wang; I Rivière
Journal:  Cancer Gene Ther       Date:  2015-02-27       Impact factor: 5.987

Review 2.  Sterility Testing for Cellular Therapies: What Is the Role of the Clinical Microbiology Laboratory?

Authors:  James E T Gebo; Anna F Lau
Journal:  J Clin Microbiol       Date:  2020-06-24       Impact factor: 5.948

3.  Comprehensive Evaluation of Compendial USP<71>, BacT/Alert Dual-T, and Bactec FX for Detection of Product Sterility Testing Contaminants.

Authors:  Matthew R England; Frida Stock; James E T Gebo; Karen M Frank; Anna F Lau
Journal:  J Clin Microbiol       Date:  2019-01-30       Impact factor: 5.948

4.  Increased sensitivity of microbiological testing of cornea organ culture medium by additional resin treatment.

Authors:  Zemra Skenderi; Laura Giurgola; Claudio Gatto; Jana D'Amato Tóthová; Axel Pruß; Jan Schroeter
Journal:  BMJ Open Ophthalmol       Date:  2018-11-10

5.  Use of 27G needles improves sensitivity and performance of ATCC anaerobe reference microorganism detection in BacT/Alert system.

Authors:  Salvatore Pasqua; Giampiero Vitale; Anna Pasquariello; Bruno Douradinha; Fabio Tuzzolino; Francesca Cardinale; Chiara Cusimano; Chiara Di Bartolo; Pier Giulio Conaldi; Danilo D'Apolito
Journal:  Mol Ther Methods Clin Dev       Date:  2021-01-26       Impact factor: 6.698

Review 6.  Cell-Based Therapy Manufacturing in Stirred Suspension Bioreactor: Thoughts for cGMP Compliance.

Authors:  Suman C Nath; Lane Harper; Derrick E Rancourt
Journal:  Front Bioeng Biotechnol       Date:  2020-11-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.